Federal Register / Vol. 72, No. 195 / Wednesday, October 10, 2007 / Notices 57595 

Date: October 29–30, 2007. 

Time: 8 a.m. to 9 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting). 

Contact Person: Malgorzata Klosek, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4188, 

MSC 7849, Bethesda, MD 20892, 301–435–

2211, Klosekm@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 2, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4991 Filed 10–9–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice Meeting 

Notice is hereby given of a change in 

the meeting of the Pathobiology of 

Kidney Disease Study Section, October 

11, 2007, 8 a.m. to October 12, 2007, 5 

p.m., Hotel Rouge, 1315 16th Street, 

NW., Washington, DC 20036 which was 

published in the Federal Register on 

September 21, 2007, 72 FR 54051–

54054. 

The meeting will be held one day 

only—October 11, 2007, 8 a.m. to 6 p.m. 

The meeting location remains the same. 

The meeting is closed to the public. 

Dated: October 2, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4993 Filed 10–9–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases, Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel. 

Date: November 6, 2007. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817. (Telephone Conference 

Call). 

Contact Person: Paul A. Amstad, Ph.D., 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramural 

Activities, DHHS/National Institutes of 

Health/NIAID, 6700B Rockledge Drive, MSC 

7616, Bethesda, MD 20892–7616, 301–402–

7098, pamstad@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS). 

Dated: October 3, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4990 Filed 10–9–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Statement of Organization, Functions, 

and Delegations of Authority 

Part N, National Institutes of Health 

(NIH), of the Statement of Organization, 

Functions, and Delegations of Authority 

for the Department of Health and 

Human Services (DHHS) (40 FR 22859, 

May 27, 1975, as amended most recently 

at 71 FR 1446, January 9, 2006, and 

redesignated from Part HN as Part N at 

60 FR 56605, November 9, 1995), is 

amended as set forth below to reflect the 

transfer of the bioengineering and 

physical science functions from the 

Office of the Director, Office of 

Management, Office of Research 

Services (NAM5, formerly HNAM5), to 

the National Institute of Biomedical 

Imaging and Bioengineering (N8, 

formerly HN8). 

Section N–B, Organization and 

Functions, is amended by replacing the 

current section N86 (formerly HN86) 

with the following: 

Intramural Research Programs (N86, 

formerly HN86). Responsible for all 

aspects of NIBIB intramural research, 

including staffing, facilities, and 

research programs. Also includes the 

Laboratory of Bioengineering and 

Physical Science, which contributes to 

the advancement of NIH research by the 

application of engineering, 

mathematics, and the physical sciences 

to the solution of problems in biology 

and medicine through (1) consultations 

and collaborative research with NIH 

intramural scientists in the areas of 

measurement, imaging, mathematical 

analysis, and modeling and the design 

of specialized research protocols and 

equipment; (2) proposing and 

developing theoretical and experimental 

methods, including novel 

instrumentation, to meet long-term 

needs of the NIH Intramural Research 

Program; and (3) serving as a liaison to 

other NIH and non–NIH organizations 

with bioengineering and physical 

science expertise to obtain and 

disseminate information on 

technological resources and 

development applicable to NIH 

intramural research problems. 

Section N–B, Organization and 

Functions, under the heading ‘‘Office of 

Research Services (NAM5, formerly 

HNAM5)’’ is amended as follows: 

Delete the ‘‘Division of Bioengineering 

and Physical Science (NAM58, formerly 

HNAM58)’’ in its entirety. 

Delegations of Authority Statement: 

All delegations and redelegations of 

authority to officers and employees of 

NIH that were in effect immediately 

prior to the effective date of this 

reorganization and are consistent with 

this reorganization shall continue in 

effect in them or their successors, 

pending further redelegation. 

Dated: September 28, 2007. 

Raynard S. Kington, 

Acting Director, National Institutes of Health. 

[FR Doc. E7–19933 Filed 10–9–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: Devices for Countercurrent 

Chromatography 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 


rwilkins on PROD1PC63 with NOTICES